The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails.
Shares of ImmunityBio ticked higher after the company said the European Medicines Agency recommended granting a conditional marketing authorization for its treatment for non-muscle invasive bladder ...
ImmunityBio (NASDAQ: IBRX), a leading immunotherapy company, announced today that the European Medicines Agency has ...
King Charles III was diagnosed with an unspecified form of cancer on Feb.
Investing.com -- ImmunityBio (NASDAQ:IBRX) stock rose 3.9% Friday after the European Medicines Agency (EMA) recommended granting conditional marketing authorization for its bladder cancer therapy ...
1hon MSN
Great Ayton's Margaret has spent 49 years fundraising for cancer research after losing her dad
Margaret Stevens, chair of the Great Ayton Cancer Research volunteer group, has dedicated decades to helping raise funds to ...
Urinary incontinence affects millions globally. It is an uncontrolled release of urine. Causes include aging, obesity, and ...
Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical ...
Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...
Detailed price information for Cg Oncology Inc (CGON-Q) from The Globe and Mail including charting and trades.
Margaret Stevens of Great Ayton marks nearly 50 years fundraising for Yorkshire Cancer Research after losing her father to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback